BRCA2 and cancer: Considering the type of gene altered in relation to the cancer type or the cancer family history of the patient, we observed a high prevalence of BRCA1 and BRCA2 pathogenic variants in both patients with personal and family history of breast cancer (12.6% (97/768) and 8.7% (9/103), respectively).